AVIR
Atea Pharmaceuticals, Inc.
+0.15 (+2.91%)5.30USD83.0K成交股數425M市值–本益比(近四季)1.2股價營收比–營收年增(近四季)2026-11-11下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 25K · 0.00 |
| 近 180 天 淨額 | 25K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | 06-23 | DUNCAN BARBARA GAYLE | Director | M 選擇權執行 | 29.6K | – | – | 92.3K | SEC |
| 2026-06-18 | 06-23 | Polsky Bruce | Director | M 選擇權執行 | 29.6K | – | – | 125K | SEC |
| 2026-06-18 | 06-23 | Adams Jerome M. | Director | M 選擇權執行 | 29.6K | – | – | 92.3K | SEC |
| 2026-06-18 | 06-23 | BERGER FRANKLIN M | Director | M 選擇權執行 | 29.6K | – | – | 536K | SEC |
| 2026-06-18 | 06-23 | Lucidi Bruno | Director | M 選擇權執行 | 29.6K | – | – | 142K | SEC |
| 2026-06-18 | 06-23 | Murphy Polly A. | Director | M 選擇權執行 | 29.6K | – | – | 122K | SEC |
| 2026-05-18 | 05-21 | Murphy Polly A. | Director | P 公開市場買進 | 6.1K | 4.17 | 25K | 92.1K | SEC |
| 2026-03-11 | 03-13 | Corcoran Andrea | See Remarks | M 選擇權執行 | 60.0K | 1.24 | 74K | 824K | SEC |
| 2026-02-03 | 02-03 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M 選擇權執行 | 300K | 1.24 | 372K | 768K | SEC |
| 2026-01-31 | 02-03 | Vavricka John | Chief Commercial Officer | M 選擇權執行 | 42.1K | – | – | 94.2K | SEC |
| 2026-01-31 | 02-03 | Vavricka John | Chief Commercial Officer | F 繳稅扣股 | 11.6K | 4.24 | 49K | 82.6K | SEC |
| 2026-01-31 | 02-03 | Horga Maria Arantxa | Chief Medical Officer | F 繳稅扣股 | 16.1K | 4.24 | 68K | 96.1K | SEC |
| 2026-01-31 | 02-03 | Horga Maria Arantxa | Chief Medical Officer | M 選擇權執行 | 51.3K | – | – | 112K | SEC |
| 2026-01-31 | 02-03 | Foster Wayne | EVP, Chief Accounting Officer | M 選擇權執行 | 41.3K | – | – | 91.5K | SEC |
| 2026-01-31 | 02-03 | Foster Wayne | EVP, Chief Accounting Officer | F 繳稅扣股 | 12.1K | 4.24 | 51K | 79.3K | SEC |
| 2026-01-31 | 02-03 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M 選擇權執行 | 273K | – | – | 574K | SEC |
| 2026-01-31 | 02-03 | Sommadossi Jean-Pierre | President, CEO, and Chairman | F 繳稅扣股 | 106K | 4.24 | 450K | 468K | SEC |
| 2026-01-31 | 02-03 | Corcoran Andrea | See Remarks | M 選擇權執行 | 54.9K | – | – | 780K | SEC |
| 2026-01-31 | 02-03 | Corcoran Andrea | See Remarks | F 繳稅扣股 | 16.1K | 4.24 | 68K | 764K | SEC |
| 2026-01-31 | 02-03 | Hammond Janet MJ | Chief Development Officer | M 選擇權執行 | 58.0K | – | – | 142K | SEC |
| 2026-01-31 | 02-03 | Hammond Janet MJ | Chief Development Officer | F 繳稅扣股 | 14.1K | 4.24 | 60K | 128K | SEC |
| 2025-06-20 | 06-24 | Adams Jerome M. | Director | M 選擇權執行 | 29.6K | – | – | 62.8K | SEC |
| 2025-06-20 | 06-24 | Lucidi Bruno | Director | M 選擇權執行 | 29.6K | – | – | 113K | SEC |
| 2025-06-20 | 06-24 | Polsky Bruce | Director | M 選擇權執行 | 29.6K | – | – | 95.2K | SEC |
| 2025-06-20 | 06-24 | BERGER FRANKLIN M | Director | M 選擇權執行 | 29.6K | – | – | 506K | SEC |
| 2025-06-20 | 06-24 | Murphy Polly A. | Director | M 選擇權執行 | 29.6K | – | – | 86.0K | SEC |
| 2025-06-20 | 06-24 | Duncan Barbara Gayle | Director | M 選擇權執行 | 29.6K | – | – | 62.8K | SEC |
| 2025-05-18 | 05-20 | Murphy Polly A. | Director | P 公開市場買進 | 6.1K | 4.17 | 25K | 92.1K | SEC |
| 2025-01-31 | 02-04 | Foster Wayne | EVP, Chief Accounting Officer | M 選擇權執行 | 33.3K | – | – | 54.2K | SEC |
| 2025-01-31 | 02-04 | Foster Wayne | EVP, Chief Accounting Officer | A 獲配股票 | 8.0K | – | – | 62.2K | SEC |
| 2025-01-31 | 02-04 | Foster Wayne | EVP, Chief Accounting Officer | F 繳稅扣股 | 12.1K | 3.06 | 37K | 50.1K | SEC |
| 2025-01-31 | 02-04 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M 選擇權執行 | 173K | – | – | 290K | SEC |
| 2025-01-31 | 02-04 | Sommadossi Jean-Pierre | President, CEO, and Chairman | A 獲配股票 | 99.5K | – | – | 390K | SEC |
| 2025-01-31 | 02-04 | Sommadossi Jean-Pierre | President, CEO, and Chairman | F 繳稅扣股 | 88.6K | 3.06 | 271K | 301K | SEC |
| 2025-01-31 | 02-04 | Corcoran Andrea | See Remarks | M 選擇權執行 | 44.4K | – | – | 723K | SEC |
| 2025-01-31 | 02-04 | Corcoran Andrea | See Remarks | A 獲配股票 | 10.5K | – | – | 733K | SEC |
| 2025-01-31 | 02-04 | Corcoran Andrea | See Remarks | F 繳稅扣股 | 16.1K | 3.06 | 49K | 717K | SEC |
| 2025-01-31 | 02-04 | Horga Maria Arantxa | Chief Medical Officer | M 選擇權執行 | 41.5K | – | – | 67.2K | SEC |
| 2025-01-31 | 02-04 | Horga Maria Arantxa | Chief Medical Officer | A 獲配股票 | 9.8K | – | – | 76.9K | SEC |
| 2025-01-31 | 02-04 | Vavricka John | Chief Commercial Officer | M 選擇權執行 | 33.3K | – | – | 54.8K | SEC |
| 2025-01-31 | 02-04 | Vavricka John | Chief Commercial Officer | A 獲配股票 | 8.8K | – | – | 63.6K | SEC |
| 2025-01-31 | 02-04 | Vavricka John | Chief Commercial Officer | F 繳稅扣股 | 11.5K | 3.06 | 35K | 52.1K | SEC |
| 2025-01-31 | 02-04 | Hammond Janet MJ | Chief Development Officer | M 選擇權執行 | 46.8K | – | – | 84.3K | SEC |
| 2025-01-31 | 02-04 | Hammond Janet MJ | Chief Development Officer | A 獲配股票 | 11.3K | – | – | 95.5K | SEC |
| 2025-01-31 | 02-04 | Hammond Janet MJ | Chief Development Officer | F 繳稅扣股 | 14.1K | 3.06 | 43K | 81.4K | SEC |
| 2025-01-31 | 02-04 | Horga Maria Arantxa | Chief Medical Officer | F 繳稅扣股 | 16.1K | 3.06 | 49K | 60.9K | SEC |
| 2025-01-16 | 01-17 | BERGER FRANKLIN M | Director | P 公開市場買進 | 10.0K | 3.36 | 34K | 477K | SEC |
| 2025-01-16 | 01-17 | BERGER FRANKLIN M | Director | P 公開市場買進 | 10.0K | 3.36 | 34K | 477K | SEC |
| 2025-01-15 | 01-17 | BERGER FRANKLIN M | Director | P 公開市場買進 | 15.0K | 3.19 | 48K | 467K | SEC |
| 2025-01-15 | 01-17 | BERGER FRANKLIN M | Director | P 公開市場買進 | 15.0K | 3.19 | 48K | 467K | SEC |
| 2024-12-10 | 12-12 | BERGER FRANKLIN M | Director | S 公開市場賣出 | 360K | 2.85 | 1.0M | 452K | SEC |
| 2024-09-19 | 09-19 | Sommadossi Jean-Pierre | President, CEO, and Chairman | S 公開市場賣出(10b5-1) | 1.8K | 4.00 | 7K | 5.9M | SEC |
| 2024-09-18 | 09-19 | Sommadossi Jean-Pierre | President, CEO, and Chairman | S 公開市場賣出(10b5-1) | 22.2K | 4.03 | 89K | 5.9M | SEC |
| 2024-09-17 | 09-19 | Sommadossi Jean-Pierre | President, CEO, and Chairman | S 公開市場賣出(10b5-1) | 33.9K | 4.05 | 137K | 5.9M | SEC |
| 2024-06-20 | 06-21 | Polsky Bruce | Director | S 公開市場賣出 | 17.5K | 3.49 | 61K | 65.6K | SEC |
| 2024-06-16 | 06-18 | Duncan Barbara Gayle | Director | M 選擇權執行 | 33.1K | – | – | 33.1K | SEC |
| 2024-06-16 | 06-18 | Polsky Bruce | Director | M 選擇權執行 | 33.1K | – | – | 83.2K | SEC |
| 2024-06-16 | 06-18 | BERGER FRANKLIN M | Director | M 選擇權執行 | 33.1K | – | – | 812K | SEC |
| 2024-06-16 | 06-18 | Lucidi Bruno | Director | M 選擇權執行 | 33.1K | – | – | 83.2K | SEC |
| 2024-06-16 | 06-18 | Murphy Polly A. | Director | M 選擇權執行 | 33.1K | – | – | 56.4K | SEC |
| 2024-06-16 | 06-18 | Adams Jerome M. | Director | M 選擇權執行 | 33.1K | – | – | 33.1K | SEC |
| 2024-06-05 | 06-07 | Sommadossi Jean-Pierre | President, CEO, and Chairman | S 公開市場賣出(10b5-1) | 1.0K | 4.00 | 4K | 5.9M | SEC |
| 2024-02-01 | 02-02 | Vavricka John | Chief Commercial Officer | S 公開市場賣出 | 11.8K | 3.84 | 45K | 21.5K | SEC |
| 2024-02-01 | 02-02 | Hammond Janet MJ | Chief Development Officer | S 公開市場賣出 | 14.0K | 3.84 | 54K | 35.4K | SEC |
| 2024-02-01 | 02-02 | Foster Wayne | EVP, Chief Accounting Officer | S 公開市場賣出 | 12.5K | 3.84 | 48K | 20.9K | SEC |
| 2024-02-01 | 02-02 | Horga Maria Arantxa | Chief Medical Officer | S 公開市場賣出 | 15.9K | 3.84 | 61K | 25.7K | SEC |
| 2024-02-01 | 02-02 | Sommadossi Jean-Pierre | President, CEO, and Chairman | S 公開市場賣出(10b5-1) | 56.9K | 3.85 | 219K | 117K | SEC |
| 2024-02-01 | 02-02 | Corcoran Andrea | See Remarks | S 公開市場賣出 | 15.8K | 3.84 | 61K | 670K | SEC |
| 2024-01-31 | 02-02 | Horga Maria Arantxa | Chief Medical Officer | M 選擇權執行 | 41.5K | – | – | 41.5K | SEC |
| 2024-01-31 | 02-02 | Vavricka John | Chief Commercial Officer | M 選擇權執行 | 33.3K | – | – | 33.3K | SEC |
| 2024-01-31 | 02-02 | Hammond Janet MJ | Chief Development Officer | M 選擇權執行 | 46.8K | – | – | 49.4K | SEC |
| 2024-01-31 | 02-02 | Foster Wayne | EVP, Chief Accounting Officer | M 選擇權執行 | 33.3K | – | – | 33.3K | SEC |
| 2024-01-31 | 02-02 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M 選擇權執行 | 173K | – | – | 173K | SEC |
| 2024-01-31 | 02-02 | Corcoran Andrea | See Remarks | M 選擇權執行 | 44.4K | – | – | 686K | SEC |
| 2022-11-14 | 11-15 | BERGER FRANKLIN M | Director | S 公開市場賣出 | 16.2K | 5.16 | 83K | 778K | SEC |
| 2022-11-11 | 11-15 | BERGER FRANKLIN M | Director | S 公開市場賣出 | 25.5K | 5.15 | 131K | 795K | SEC |
| 2021-12-20 | 12-21 | Murphy Polly A. | Director | P 公開市場買進 | 12.0K | 8.57 | 103K | 23.3K | SEC |
| 2020-11-03 | 11-05 | Chen Bihua | Director,TenPercentOwner | C 轉換 | 6.4M | – | – | 6.4M | SEC |
| 2020-11-03 | 11-05 | Cormorant Asset Management, LP | Other | C 轉換 | 6.4M | – | – | 6.4M | SEC |
| 2020-11-03 | 11-05 | Cormorant Global Healthcare Master Fund, LP | TenPercentOwner | C 轉換 | 6.4M | – | – | 6.4M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 12.0M | 55.8M | 新進 | 新進 |
| BlackRock, Inc. | 8.7M | 40.5M | 新進 | 新進 |
| BML Capital Management, LLC | 7.0M | 32.3M | 新進 | 新進 |
| TANG CAPITAL MANAGEMENT LLC | 4.8M | 22.4M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.0M | 13.8M | 新進 | 新進 |
| Bain Capital Life Sciences Investors, LLC | 2.1M | 9.7M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.0M | 9.1M | 新進 | 新進 |
| STATE STREET CORP | 1.7M | 7.7M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 1.5M | 7.0M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 1.3M | 6.0M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 1.1M | 5.3M | 新進 | 新進 |
| Rosalind Advisors, Inc. | 1.1M | 5.0M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 946K | 4.4M | 新進 | 新進 |
| NORTHERN TRUST CORP | 755K | 3.5M | 新進 | 新進 |
| MORGAN STANLEY | 720K | 3.3M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 630K | 2.9M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 611K | 2.8M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 531K | 2.5M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 470K | 2.2M | 新進 | 新進 |
| CM Management, LLC | 355K | 1.7M | 新進 | 新進 |
| BARCLAYS PLC | 349K | 1.6M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 345K | 1.6M | 新進 | 新進 |
| BANQUE PICTET & CIE SA | 345K | 1.6M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 305K | 1.4M | 新進 | 新進 |
| Nuveen, LLC | 284K | 1.3M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 125 -2 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 125 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 59.4M · 74.1% |
| 合計季末市值 | 266M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 7.7M |
|---|---|
| 與上期比 | -0.1% |
| 佔流通股數 | 9.56% |
| 日均成交量 | 186K |
| 回補天數 | 41.2 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 7.7M | -0.1% | 9.56% | 186K | 41.2 |
| 2026-08-14 | 7.7M | +1.9% | 9.56% | 288K | 26.6 |
| 2026-07-31 | 7.5M | -3.0% | 9.39% | 417K | 18.0 |
| 2026-07-15 | 7.8M | +11.0% | 9.67% | 341K | 22.8 |
| 2026-06-30 | 7.0M | -1.2% | 8.72% | 436K | 16.0 |
| 2026-06-15 | 7.1M | -6.0% | 8.82% | 245K | 28.9 |
| 2026-05-29 | 7.5M | -0.9% | 9.39% | 315K | 23.9 |
| 2026-05-15 | 7.6M | +1.4% | 9.47% | 385K | 19.7 |
| 2026-04-30 | 7.5M | -2.6% | 9.34% | 263K | 28.5 |
| 2026-04-15 | 7.7M | +1.3% | 9.58% | 346K | 22.2 |
| 2026-03-31 | 7.6M | -5.1% | 9.46% | 487K | 15.6 |
| 2026-03-13 | 8.0M | +1.4% | 9.97% | 810K | 9.9 |
| 2026-02-27 | 7.9M | +2.1% | 9.83% | 389K | 20.3 |
| 2026-02-13 | 7.7M | +0.7% | 9.63% | 523K | 14.8 |
| 2026-01-30 | 7.7M | +5.0% | 9.56% | 642K | 11.9 |
| 2026-01-15 | 7.3M | +5.5% | 9.10% | 353K | 20.7 |
| 2025-12-31 | 6.9M | +1.7% | 8.63% | 421K | 16.4 |
| 2025-12-15 | 6.8M | +0.9% | 8.49% | 326K | 20.9 |
| 2025-11-28 | 6.7M | -1.6% | 8.41% | 391K | 17.3 |
| 2025-11-14 | 6.9M | +7.0% | 8.55% | 456K | 15.0 |
| 2025-10-31 | 6.4M | +5.8% | 7.98% | 392K | 16.3 |
| 2025-10-15 | 6.1M | +0.7% | 7.55% | 560K | 10.8 |
| 2025-09-30 | 6.0M | -2.1% | 7.49% | 283K | 21.2 |
| 2025-09-15 | 6.1M | +4.7% | 7.65% | 168K | 36.4 |
| 2025-08-29 | 5.9M | +19.8% | 7.31% | 348K | 16.8 |
| 2025-08-15 | 4.9M | +9.8% | 6.10% | 324K | 15.1 |